Mereo BioPharma Shares Owned By Institutions vs. Number Of Employees
| 0A9G Stock | 3.55 0.15 4.41% |
For Mereo BioPharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mereo BioPharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mereo BioPharma Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mereo BioPharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mereo BioPharma Group over time as well as its relative position and ranking within its peers.
Mereo |
Mereo BioPharma Group Number Of Employees vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Mereo BioPharma's current stock value. Our valuation model uses many indicators to compare Mereo BioPharma value to that of its competitors to determine the firm's financial worth. Mereo BioPharma Group is number one stock in shares owned by institutions category among its peers. It also is number one stock in number of employees category among its peers creating about 0.48 of Number Of Employees per Shares Owned By Institutions. The ratio of Shares Owned By Institutions to Number Of Employees for Mereo BioPharma Group is roughly 2.07 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mereo BioPharma's earnings, one of the primary drivers of an investment's value.Mereo Number Of Employees vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Mereo BioPharma |
| = | 68.29 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Mereo BioPharma |
| = | 33 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Mereo Number Of Employees vs Competition
Mereo BioPharma Group is number one stock in number of employees category among its peers. The total workforce of Industrials industry is presently estimated at about 9,429. Mereo BioPharma adds roughly 33.0 in number of employees claiming only tiny portion of equities under Industrials industry.
Mereo BioPharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Mereo BioPharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Mereo BioPharma will eventually generate negative long term returns. The profitability progress is the general direction of Mereo BioPharma's change in net profit over the period of time. It can combine multiple indicators of Mereo BioPharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Loss | -39.3 M | -41.3 M | |
| Income Tax Expense | -2.2 M | -2.3 M | |
| Net Loss | -39.3 M | -41.3 M | |
| Change To Netincome | -15.1 M | -14.3 M |
Mereo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Mereo BioPharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Mereo BioPharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Mereo BioPharma's important profitability drivers and their relationship over time.
Use Mereo BioPharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mereo BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will appreciate offsetting losses from the drop in the long position's value.Mereo BioPharma Pair Trading
Mereo BioPharma Group Pair Trading Analysis
The ability to find closely correlated positions to Mereo BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mereo BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mereo BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mereo BioPharma Group to buy it.
The correlation of Mereo BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mereo BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mereo BioPharma Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mereo BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Mereo BioPharma position
In addition to having Mereo BioPharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Communication Thematic Idea Now
Communication
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.